Login / Signup

Angiotensin- neprilysin inhibitors: should we initiate them in hospital for patients with acute decompensated heart failure?

Samuel Grigg
Published in: BMJ evidence-based medicine (2019)
Keyphrases
  • heart failure
  • angiotensin converting enzyme
  • angiotensin ii
  • healthcare
  • left ventricular
  • acute heart failure
  • cardiac resynchronization therapy
  • acute care
  • adverse drug
  • atrial fibrillation
  • ejection fraction